Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-058913
Filing Date
2013-02-14
Accepted
2013-02-14 12:45:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d485156dsc13ga.htm SC 13G/A 42353
  Complete submission text file 0001193125-13-058913.txt   43630
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 13609612
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 99 SUMMER STREET BOSTON MA 02110
FRONTIER CAPITAL MANAGEMENT CO LLC (Filed by) CIK: 0001216488 (see all company filings)

EIN.: 043492668 | State of Incorp.: DE
Type: SC 13G/A